No Data
No Data
Insmed Presents Additional Data From Pivotal ASPEN Study Of Brensocatib In Patients With Bronchiectasis At The 7th World Bronchiectasis Conference
—New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Brensocatib 25 mg Versus Placebo——Additional Exploratory Endpoints to be Presented, Including FVC and
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In First Half 2024 – Where Do Nvidia, Tesla, Palantir, GameStop Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.Here is a look at the most-
MicroStrategy Unusual Options Activity For July 02
Investors with a lot of money to spend have taken a bearish stance on MicroStrategy (NASDAQ:MSTR).And retail traders should know.We noticed this today when the trades showed up on publicly available o
What the Options Market Tells Us About Super Micro Computer
Investors with a lot of money to spend have taken a bearish stance on Super Micro Computer (NASDAQ:SMCI).And retail traders should know.We noticed this today when the trades showed up on publicly avai
SA Subscribers Believe This Will Be the Top-performing S&P 500 Stock in H2
Bitcoin Bounces Back Above $63,000: Could Crypto Become the New 'Trump Trade'?
Bitcoin recently regained its momentum and rebounded above $63,000 on Monday after hitting a low of $60,000 at the end of June. Despite facing various challenges such as a complex and ever-changing macro environment, sell-off shocks, and a slowdown in ETF demand,